ArticleBMC psychiatry2026
Distinguishing variability in hoarding symptom course across time.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAlthough hoarding disorder (HD) is commonly characterized as a chronic and progressive condition, relatively little is known about its longitudinal course and the factors that contribute to the progression, maintenance, or remission of hoarding symptoms. The current study, the first prospective investigation of hoarding symptom course, aims to identify and characterize patterns of hoarding symptom chronicity in a large sample of adults with clinically significant hoarding.
methodsParticipants who were enrolled in the internet-based Brain Health Registry completed online self-report measures of hoarding symptom severity at 6-month intervals over a period of 5 years. In a sample of 1,275 participants with clinically significant hoarding symptoms (79% with follow-up ≥ 4 years, n = 1,004), latent class mixed modeling (LCMM) was used to identify subgroups of individuals with similar symptom trajectories. Data-driven trajectories were then compared to four previously described theory-driven trajectories, and the demographic and clinical characteristics associated with trajectory class membership were assessed.
resultsLCMM yielded three distinct hoarding symptom trajectories: (1) persistent clinically severe symptoms ("severe": n = 203, 15.9%), (2) persistent mild or subclinical symptoms ("mild": n = 955, 74.9%), and (3) rapidly improving symptoms ("improving": n = 117, 9.2%). Although this data-driven model characterized most participants as exhibiting a predominantly chronic course (90.8%), individuals in the "improving" class experienced sustained remission of hoarding symptoms within 18 months and were distinguished by later age of onset (median age = 47.5 years) and elevated prevalence of self-reported PTSD (20.2%). However, when integrated with the theory-driven framework, substantial heterogeneity in symptom progression emerged among those in the "mild" and "severe" classes, with 29% improving and 20% worsening over time. Individuals in the "severe" class with worsening symptoms (n = 41) were uniquely characterized by childhood-onset hoarding symptoms (median age = 13 years) and elevated prevalence of self-reported ADHD (35.0%).
conclusionIndividuals with clinically relevant hoarding exhibit marked variability in longitudinal symptom course, including a distinct subgroup characterized by rapid improvement; these individuals had unique clinical and demographic characteristics compared to the other groups. These findings underscore the importance of monitoring intraindividual change and may inform early intervention and prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.